Ocular Pathology / Ocular Oncology and Tumors

FP0033 : SAFETY ANDEFFICACY OFINDIGENOUSLY DEVELOPED RUTHENIUM106 EYEPLAQUE FOR BRACHYTHERAPYOF OCULARTUMOURS

FP0340 : CLINICO-PATHOLOGICAL SIGNIFICANCE OF CD24 GENE EXPRESSION IN OCULAR MALIGNANCIES

FP0752 : STUDY OF FESEM AND RAMAN SPECTROSCOPY IN OPHTHALMIC PATHOLOGY SPECIMENS

FP1343 : TAMING THE BEAST – ALLOGENIC SLET IN OSSN

FP1410 : CORRELATION OF SECONDARY GLAUCOMA AND HIGH-RISK HISTOPATHOLOGY FEATURES IN RETINOBLASTOMA

FP1455 : IMPACT OF COVID-19 ON FEATURES AND MANAGEMENT OF 830 CONSECUTIVE PATIENTS WITH UVEAL MELANOMA

FP1642 : TREATMENT OUTCOME WITH SIMULTANEOUS INTRAVITREAL CHEMOTHERAPY IN THE RETINOBLASTOMA

FP2055 : AN ANALYSIS TO THE KEY HISTOPATHOLOGICAL POINTS PREDICTING THE RECURRENCE OF PTERYGIUM

FP2180 : SUBCONJUNCTIVAL PERILESIONAL INTERFERON ALPHA 2B IN THE TREATMENT OF OSSN.

FP2238 : COATS DISEASE – CLINICO-PATHOLOGICAL CORRELATION OF 17 CASES FROM TWO EYE CARE CENTRES IN INDIA